 |
|
|
|
|
|
|
|
 |
Results for 'Transdermal & Transmucosal Delivery of Therapeutic' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
Transdermal Drug Delivery
Technologies, Markets and Companies
|
March 2008 |
£1240 |
48 % |
Transdermal and Topical Drug Delivery
1st Edition
|
June 2005 |
£65 |
34 % |
The Global Drug Delivery Market
Research Trends and Market Outlook
|
May 2006 |
£990 |
17.85 % |
Premium Company Profile Antares Pharma
|
November 2007 |
£265 |
17.5 % |
Nanoparticulate Drug Delivery Systems
|
April 2007 |
£115 |
17.5 % |
Drug Delivery Series I-IV
|
April 2007 |
£3610 |
16.1 % |
Drug Delivery Technology: Revolutionizing Diabetes Treatment
|
September 2007 |
£945 |
15.5 % |
Drug Delivery Technology
Revolutionizing Diabetes Treatment
|
September 2007 |
£945 |
15.5 % |
U.S. Drug Delivery Systems Market
Emerging Technologies, Strategic Alliances, Patent Disputes,
Market Size & Forecasts and R&D Activities
|
April 2001 |
£545 |
15.4 % |
Advanced Drug Delivery Systems: Probing the Route to Growth
New Developments, New Technologies, Companies and Trends
|
October 2001 |
£705 |
15.4 % |
Drug Delivery Technologies: Players, products & prospects to 2015
|
November 2007 |
£1795 |
13 % |
Innovation in Drug Delivery
The future of nanotechnology and non-invasive protein delivery
|
November 2006 |
£1495 |
12.25 % |
Opportunities in Drug Delivery
Identifying hot technologies, companies and markets
|
September 2003 |
£400 |
11.9 % |
Drug Delivery Systems
US Market Outlook, Advances for Pharma, Biotech & Medical Devices
|
September 2006 |
£1140 |
11.9 % |
Assessing Bioavailablility of Drug Delivery Systems
Mathematical Modeling
|
May 2005 |
£75 |
11.2 % |
Drug Delivery Technology: Revolutionizing CNS Therapies
|
December 2007 |
£945 |
9.45 % |
Dermatological and Cosmeceutical Development: Absorption Efficacy and Toxicity
|
August 2007 |
£130 |
9.1 % |
Nanomedicine
Innovative Approach in Healthcare Research and Commercial Opportunities
|
April 2005 |
£395 |
9.1 % |
Drug Repositioning Strategies
Innovative Strategies To Boost Pipeline Productivity
|
June 2007 |
£1495 |
7.35 % |
Biotech Drug Delivery Systems
Key Company Intelligence & Market Outlook to 2012
|
February 2007 |
£1299 |
6.65 % |
Cardiovascular Drug Delivery
Technologies, Markets and Companies
|
March 2008 |
£1090 |
5.95 % |
Drug Delivery in Central Nervous System Disorders
Technologies, Markets and Companies
|
March 2008 |
£1240 |
4.9 % |
Therapeutic Proteins
|
February 2005 |
£1999 |
4.9 % |
Global Biotech Report 2006, The
The rise of the Biotech blockbusters
|
September 2006 |
£4999 |
4.9 % |
Pain Therapeutics
Drugs, Markets and Companies
|
March 2008 |
£1490 |
4.9 % |
World Biotech Market 2005, The
|
June 2005 |
£4999 |
4.55 % |
Pain Therapeutics 2005
Market Dynamics and Outlook
|
May 2005 |
£990 |
4.2 % |
Antiviral Therapeutics
Technologies, Markets and Companies
|
March 2008 |
£1390 |
3.85 % |
Drug Delivery in Cancer
Technologies, Markets and Companies
|
March 2008 |
£1490 |
3.85 % |
The Global Pain Therapeutics Market
Market Analysis, R&D Pipelines and Competitive Landscape
|
October 2007 |
£1515 |
3.85 % |
Combination Therapies
Benefits and Challenges in Drug, Device, and Biologicals Development
|
October 2005 |
£1945 |
3.5 % |
Diabetes, Metabolic Syndrome and Cardiovascular Disease Markets
Reshaping Tomorrow's Diabetes Market
|
October 2005 |
£990 |
3.5 % |
Stakeholder Opinions: Parkinson's Disease
Review of Key Commercial Opportunities in the Symptomatic Treatment Market
|
July 2006 |
£2110 |
3.15 % |
The Women's Health Market Outlook to 2011
|
April 2007 |
£1495 |
2.8 % |
Nitric Oxide
Therapeutics, Markets and Companies
|
March 2008 |
£1390 |
2.8 % |
Nanobiotechnology
|
March 2008 |
£1740 |
2.8 % |
Gene Therapy
Technologies, Markets and Companies
|
March 2008 |
£1740 |
2.8 % |
Global Endocrine Pharmaceutical Market 2005, The
2nd Edition
|
March 2005 |
£1499 |
2.45 % |
Cell Therapy
New Drugs, Markets and Companies
|
March 2008 |
£1515 |
2.1 % |
World Generic Market Report 2007
|
November 2006 |
£595 |
1.4 % |
|
|
|
|
